Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma

The prognosis of advanced hepatocellular carcinoma (HCC) patients remains extremely poor, partially due to the development of acquired resistance to sorafenib and chemotherapy. Cabazitaxel, a semisynthetic taxane, has been approved for the therapy of docetaxel-resistant prostate cancer. However, no...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Am J Cancer Res
Main Authors: Chen, Ronggao, Cheng, Qiyang, Owusu-Ansah, Kwabena Gyabaah, Chen, Jun, Song, Guangyuan, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Jiang, Donghai, Zheng, Shusen
Formáid: Artigo
Teanga:Inglês
Foilsithe: e-Century Publishing Corporation 2018
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079161/
https://ncbi.nlm.nih.gov/pubmed/30094102
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla